日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson

在MD安德森癌症中心早期临床试验中入组的晚期非小细胞肺癌患者的治疗反应

Lim, Jeong Uk; Lin, Heather Y; Kang, Lei; Le, Hung; Tang, Tin-Yun; Champiat, Stephane; Dumbrava, Ecaterina Elena; Le, Xiuning; Naing, Aung; Piha-Paul, Sarina A; Ahnert, Jordi Rodon; Tsimberidou, Apostolia Maria; Yap, Timothy A; Fu, Siqing; Meric-Bernstam, Funda; Hong, David S

Telemedicine as a gateway to early-phase oncology trials: lessons from 14 000 patients and future directions for global access and equity

远程医疗作为早期肿瘤临床试验的途径:来自14000名患者的经验教训以及全球可及性和公平性的未来方向

Torrado, Carlos; Andersen, Clark R; Kang, Lei; Brink, Amanda L; Adesoye, Taiwo; Le, Hung; Patterson, Clover J; Poullard, Anna; Osburn, Jessica A; Tan, Harold N; Gouda, Mohamed A; Charles, Sheena; Urschel, Gabriele E; Tang, Tin-Yun; Hong, David S; Champiat, Stephane; Naing, Aung; Tsimberidou, Apostolia M; Dumbrava, Ecaterina E; Piha-Paul, Sarina A; Rodon, Jordi; Yap, Timothy A; Pohlmann, Paula R; Meric-Bernstam, Funda; Fu, Siqing

Immune-mediated diarrhea and colitis with normal biochemical, endoscopic and histologic findings: a retrospective study

免疫介导性腹泻和结肠炎伴正常生化、内镜和组织学检查结果:一项回顾性研究

Shatila, Malek; Wali, Sharada; Cruz, Carolina Colli; Takigawa, Kei; Rivera, Andres Caleb Urias; Abdul-Baki, Kian; Gupta, Tanvi; Baerman, Elliot; Lu, Linfeng; Lee, Irene Jeong-Ah; Menon, Raakhi; Salim, Hamza; Sullivan, Andrew; Vemulapalli, Varun; Natha, Cristina; Khan, Ayesha; Varatharajalu, Krishnavathana; Champiat, Stephane; Reynolds, Kerry L; Kennedy, Lucy B; Tsai, Katy; Thomas, Anusha Shirwaiker; Wang, Yinghong

First-in-human phase 1 dose-escalation study of W0180, an anti-VISTA monoclonal antibody, with and without pembrolizumab in patients with locally advanced or metastatic solid tumours

首次人体1期剂量递增研究,评估抗VISTA单克隆抗体W0180联合或不联合帕博利珠单抗治疗局部晚期或转移性实体瘤患者的疗效。

Gomez-Roca, Carlos; Champiat, Stéphane; Danlos, Francois-Xavier; Castañón Álvarez, Eduardo; Cassier, Philippe Alexandre; Dupuy, Elena; Jegou, David; Primard, Marie; Pétain, Aurélie; Saccareau, Mathilde; Gueguen-Dorbes, Geneviève; Fabre, Claire; Marabelle, Aurélien; Melero, Ignacio

Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers

Nanrilkefusp alfa (SOT101) 是一种 IL-15 受体 βγ 超激动剂,可作为单药或与抗 PD-1 药物联合用于治疗晚期癌症患者。

Stephane Champiat ,Elena Garralda ,Vladimir Galvao ,Philippe A Cassier ,Carlos Gomez-Roca ,Iphigenie Korakis ,Peter Grell ,Aung Naing ,Patricia LoRusso ,Romana Mikyskova ,Nada Podzimkova ,Milan Reinis ,Kaissa Ouali ,Andreu Schoenenberger ,Joachim Kiemle-Kallee ,Sascha Tillmanns ,Richard Sachse ,Ulrich Moebius ,Radek Spisek ,David Bechard ,Lenka Palova Jelinkova ,Irena Adkins ,Aurelien Marabelle

Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors

STING激动剂E7766治疗晚期实体瘤的I期剂量递增和药效学研究

Luke, Jason J; Pinato, David J; Juric, Dejan; LoRusso, Patricia; Hosein, Peter J; Desai, Anupam M; Haddad, Robert; de Miguel, María; Cervantes, Andrés; Kim, Won Seog; Marabelle, Aurélien; Zhang, Yan; Rong, Yuanxin; Yuan, Xiaobin; Champiat, Stéphane

Immune-related adverse events occurring rapidly after a single dose of immune checkpoint blockade

单次注射免疫检查点阻断剂后迅速发生的免疫相关不良事件

Guitton, Romain; Laparra, Ariane; Chanson, Noemie; Champiat, Stephane; Danlos, Francois-Xavier; Michot, Jean-Marie; Messayke, Sabine; Marabelle, Aurelien; Lambotte, Olivier

A Phase I, First-in-Human, Dose-Escalation, Expansion Trial of Cytokine-Encoding Synthetic mRNA Mixture Alone or with Cemiplimab in Advanced Solid Tumors

一项针对晚期实体瘤的细胞因子编码合成mRNA混合物单药或联合Cemiplimab治疗的I期、首次人体、剂量递增、扩展试验

Bechter, Oliver; Loquai, Carmen; Champiat, Stephane; Baurain, Jean-Francois; Grob, Jean-Jacques; Utikal, Jochen; Rottey, Sylvie; Berrocal, Alfonso; Hassel, Jessica C; Arance, Ana; Sanmamed, Miguel F; Boers-Sonderen, Marye; Gastman, Brian; Gebhardt, Christoffer; Delafontaine, Brant; Sahin, Ugur; Türeci, Özlem; Brueck, Patrick; Abbadessa, Giovanni; Marpadga, Rahul; Lee, Helen; Yang, Yue; Buday, Barbara; Di Genova, Gianfranco; Wang, Hong; Xia, Binfeng; Lee, Joon Sang; Lebbe, Céleste

From toxicity assessment to adaptive safety care: implementing comprehensive fast-track safety evaluation for anticancer drug development

从毒性评估到适应性安全护理:在抗癌药物研发中实施全面的快速安全评估

Champiat, S; Ouali, K; Laparra, A; Charalambous, A; Di Palma, M; Jordan, K; Massard, C; Aapro, M; Scotte, F

Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer

对于既往接受过治疗的小细胞肺癌患者,使用靶向δ样配体3的双特异性T细胞衔接器免疫疗法tarlatamab治疗时,不良事件的实用管理

Sands, Jacob M; Champiat, Stéphane; Hummel, Horst-Dieter; Paulson, Kelly G; Borghaei, Hossein; Alvarez, Jean Bustamante; Carbone, David P; Carlisle, Jennifer W; Choudhury, Noura J; Clarke, Jeffrey M; Gadgeel, Shirish M; Izumi, Hiroki; Navarro, Alejandro; Lau, Sally C M; Lammers, Philip E; Huang, Shuang; Hamidi, Ali; Mukherjee, Sujoy; Owonikoko, Taofeek K